Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Voyageur Pharmaceuticals Ltd | 0.00 | -1.30m | 9.07m | -- | -- | 7.24 | -- | -- | -0.0096 | -0.0096 | 0.00 | 0.009 | 0.00 | -- | -- | -- | -57.04 | -74.47 | -82.81 | -120.92 | -- | -- | -- | -- | 0.1615 | -279.30 | 0.0311 | -- | -- | -- | 20.21 | -- | -11.81 | -- |
Khiron Life Sciences Corp | 16.14m | -30.66m | 9.29m | 310.00 | -- | -- | -- | 0.5755 | -0.1674 | -0.1674 | 0.085 | 0.1248 | 0.3078 | 1.33 | 3.90 | 52,055.68 | -58.47 | -- | -69.10 | -- | 19.51 | -- | -190.00 | -- | 0.9133 | -- | 0.0864 | -- | 59.60 | -- | -37.81 | -- | -- | -- |
Crescita Therapeutics Inc | 16.84m | -2.98m | 11.36m | 80.00 | -- | 0.6659 | -- | 0.6742 | -0.150 | -0.150 | 0.8486 | 0.8861 | 0.6808 | 1.44 | 5.54 | 210,525.00 | -12.06 | -0.2457 | -15.07 | -0.3059 | 54.66 | 63.41 | -17.72 | -0.3518 | 2.32 | -- | 0.0568 | -- | -25.52 | 1.05 | -330.39 | -- | -1.58 | -- |
Data as of Oct 04 2024. Currency figures normalised to Voyageur Pharmaceuticals Ltd's reporting currency: Canadian Dollar CAD